| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Molecular and Cellular Biology (S.L.G., T.N.S., E.B.K., J.P.L., J.M.R.) and Breast Center (A.V.L.), Department of Medicine, Baylor College of Medicine, Houston, Texas 77030; Molecular and Cellular Endocrinology Section (R.C.H., B.K.V.), Center for Cancer Research, National Cancer Institute, National Institutes of Health, and Laboratory of Genetics and Physiology (K.M., L.H.), National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892; Cancer Research Program (C.J.O.), Garvan Institute of Medical Research, Darlinghurst, Australia; and Department of Neuroscience and Anatomy (M.A.S., T.L.W.), Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033
Address all correspondence and requests for reprints to: Jeffrey M. Rosen, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030. E-mail: jrosen{at}bcm.tmc.edu.
Targeted deletion of the bZIP transcription factor, CCAAT/enhancer binding protein-ß (C/EBPß), was shown previously to result in aberrant ductal morphogenesis and decreased lobuloalveolar development, accompanied by an altered pattern of progesterone receptor (PR) expression. Here, similar changes in the level and pattern of prolactin receptor (PrlR) expression were observed while screening for differentially expressed genes in C/EBPßnull mice. PR patterning was also altered in PrlRnull mice, as well as in mammary tissue transplants from both PrlRnull and signal transducer and activator of transcription (Stat) 5a/b-deficient mice, with concomitant defects in hormone-induced proliferation. Down-regulation of PR and activation of Stat5 phosphorylation were seen after estrogen and progesterone treatment in both C/EBPßnull and wild-type mice, indicating that these signaling pathways were functional, despite the failure of steroid hormones to induce proliferation. IGF binding protein-5, IGF-II, and insulin receptor substrate-1 all displayed altered patterns and levels of expression in C/EBPßnull mice, suggestive of a change in the IGF signaling axis. In addition, small proline-rich protein (SPRR2A), a marker of epidermal differentiation, and keratin 6 were misexpressed in the mammary epithelium of C/EBPßnull mice. Together, these data suggest that C/EBPß is a master regulator of mammary epithelial cell fate and that the correct spatial pattern of PR and PrlR expression is a critical determinant of hormone-regulated cell proliferation.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
L. M Arendt, L. C Evans, D. E Rugowski, M. J. Garcia-Barchino, H. Rui, and L. A Schuler Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes J. Endocrinol., October 1, 2009; 203(1): 99 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fernandez-Valdivia, A. Mukherjee, C. J. Creighton, A. C. Buser, F. J. DeMayo, D. P. Edwards, and J. P. Lydon Transcriptional Response of the Murine Mammary Gland to Acute Progesterone Exposure Endocrinology, December 1, 2008; 149(12): 6236 - 6250. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. P. Pai and N. D. Horseman Biphasic Regulation of Mammary Epithelial Resistance by Serotonin through Activation of Multiple Pathways J. Biol. Chem., November 7, 2008; 283(45): 30901 - 30910. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Muraoka-Cook, M. Sandahl, D. Hunter, L. Miraglia, and H. S. Earp III Prolactin and ErbB4/HER4 Signaling Interact via Janus Kinase 2 to Induce Mammary Epithelial Cell Gene Expression Differentiation Mol. Endocrinol., October 1, 2008; 22(10): 2307 - 2321. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. LaMarca and J. M. Rosen Hormones and Mammary Cell Fate--What Will I Become When I Grow Up? Endocrinology, September 1, 2008; 149(9): 4317 - 4321. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nagy, H. Wei, T.-L. Shen, X. Peng, C.-C. Liang, B. Gan, and J.-L. Guan Mammary Epithelial-specific Deletion of the Focal Adhesion Kinase Gene Leads to Severe Lobulo-Alveolar Hypoplasia and Secretory Immaturity of the Murine Mammary Gland J. Biol. Chem., October 26, 2007; 282(43): 31766 - 31776. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hiremath, J. P. Lydon, and P. Cowin The pattern of {beta}-catenin responsiveness within the mammary gland is regulated by progesterone receptor Development, October 15, 2007; 134(20): 3703 - 3712. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Taneja, S. Ha, N. K. Swenson, H. Y. Huang, P. Lee, J. Melamed, E. Shapiro, M. J. Garabedian, and S. K. Logan Cell-specific Regulation of Androgen Receptor Phosphorylation in Vivo J. Biol. Chem., December 9, 2005; 280(49): 40916 - 40924. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Grimm, A. Contreras, M.-H. Barcellos-Hoff, and J. M. Rosen Cell Cycle Defects Contribute to a Block in Hormone-induced Mammary Gland Proliferation in CCAAT/Enhancer-binding Protein (C/EBP{beta})-null Mice J. Biol. Chem., October 28, 2005; 280(43): 36301 - 36309. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, B. Zhao, V. E. Baracos, and J. J. Kennelly Effects of Bovine Somatotropin on {beta}-Casein mRNA Levels in Mammary Tissue of Lactating Cows J Dairy Sci, August 1, 2005; 88(8): 2806 - 2812. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B.R. Ewan, H. A. Oketch-Rabah, S. A. Ravani, G. Shyamala, H. L. Moses, and M. H. Barcellos-Hoff Proliferation of Estrogen Receptor-{alpha}-Positive Mammary Epithelial Cells Is Restrained by Transforming Growth Factor-{beta}1 in Adult Mice Am. J. Pathol., August 1, 2005; 167(2): 409 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Gutzman, S. E. Nikolai, D. E. Rugowski, J. J. Watters, and L. A. Schuler Prolactin and Estrogen Enhance the Activity of Activating Protein 1 in Breast Cancer Cells: Role of Extracellularly Regulated Kinase 1/2-Mediated Signals to c-fos Mol. Endocrinol., July 1, 2005; 19(7): 1765 - 1778. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Behbod and J. M. Rosen Will cancer stem cells provide new therapeutic targets? Carcinogenesis, April 1, 2005; 26(4): 703 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Tilli, R. Reiter, A. S. Oh, R. T. Henke, K. McDonnell, G. I. Gallicano, P. A. Furth, and A. T. Riegel Overexpression of an N-Terminally Truncated Isoform of the Nuclear Receptor Coactivator Amplified in Breast Cancer 1 Leads to Altered Proliferation of Mammary Epithelial Cells in Transgenic Mice Mol. Endocrinol., March 1, 2005; 19(3): 644 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Jackson-Fisher, G. Bellinger, R. Ramabhadran, J. K. Morris, K.-F. Lee, and D. F. Stern ErbB2 is required for ductal morphogenesis of the mammary gland PNAS, December 7, 2004; 101(49): 17138 - 17143. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Shi, J. P. Lydon, and M. Zhang Hormonal Defect in Maspin Heterozygous Mice Reveals a Role of Progesterone in Pubertal Ductal Development Mol. Endocrinol., September 1, 2004; 18(9): 2196 - 2207. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Mulac-Jericevic and O. M Conneely Reproductive tissue selective actions of progesterone receptors Reproduction, August 1, 2004; 128(2): 139 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Allar and T. L. Wood Expression of the Insulin-Like Growth Factor Binding Proteins during Postnatal Development of the Murine Mammary Gland Endocrinology, May 1, 2004; 145(5): 2467 - 2477. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gourdou, J. Paly, C. Hue-Beauvais, L. Pessemesse, J. Clark, and J. Djiane Expression by Transgenesis of a Constitutively Active Mutant Form of the Prolactin Receptor Induces Premature Abnormal Development of the Mouse Mammary Gland and Lactation Failure Biol Reprod, March 1, 2004; 70(3): 718 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
Functional Characterization of Mammary Stem Cells: JEFFREY M. ROSEN,1 BRYAN E. WELM,3 STACEY B. TEPERA,1 SANDRA L. GRIMM,1 TERESA VENEZIA,2 MARGARET A. GOODELL,2 TIMOTHY A. GRAUBERT,4 ZENA WERB,3 YI LI,5, 6 AND HAROLD E. VARMUS,6 1 Department of Molecular and Cellular Biology; 2 Center for Cell and Gene Therapy and Department of Pediatrics; 5 Baylor Breast Center, Baylor College of Medicine, Houston, Texas 77030; 3Department of Anatomy, University of California, San Francisco, California 94143; 4Division of Bone Marrow Transplantation and Stem Cell Biology, Washington University School of Medicine, St. Louis, Missouri 63110; and 6 Memorial Sloan Kettering Cancer Center, New York, NY 10021 Toxicol Pathol, January 1, 2004; 32(1): 148 - 149. [PDF] |
||||
![]() |
Y. Li, B. Welm, K. Podsypanina, S. Huang, M. Chamorro, X. Zhang, T. Rowlands, M. Egeblad, P. Cowin, Z. Werb, et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells PNAS, December 23, 2003; 100(26): 15853 - 15858. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Lee, P. Zhang, M. Ivanova, S. Bonnette, S. Oesterreich, J. M. Rosen, S. Grimm, R. C. Hovey, B. K. Vonderhaar, C. R. Kahn, et al. Developmental and Hormonal Signals Dramatically Alter the Localization and Abundance of Insulin Receptor Substrate Proteins in the Mammary Gland Endocrinology, June 1, 2003; 144(6): 2683 - 2694. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |